Metabolism
Purity: 99.1%
Retatrutida
Next-generation triple GIP/GLP-1/glucagon agonist.
Description
Retatrutide adds glucagon receptor activation to the dual GIP/GLP-1 pathway, and is studied in research models on energy expenditure and lipid metabolism. Available in several presentations depending on the protocol's required dose.
Tested batches (COA)
| Batch number | Purity | Tested on |
|---|---|---|
| Novalabs-2026-0056 | 99.1% | 2026-07-10 |